MOLECULAR HEALTH GMBH has a total of 41 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets computer technology, biotechnology and measurement are MOLECULAR PROFILING INST INC, PE DIAGNOSTIK GMBH and CYTOLON AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Australia | 7 | |
#3 | United States | 7 | |
#4 | Canada | 3 | |
#5 | Brazil | 2 | |
#6 | Chile | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | Singapore | 2 | |
#11 | Hungary | 1 | |
#12 | Japan | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Brock Stephan | 35 |
#2 | Jackson David B | 29 |
#3 | Stein Martin | 27 |
#4 | Zien Alexander | 18 |
#5 | Taglang Guillaume | 18 |
#6 | Voss Hartmut | 16 |
#7 | Sulzer Bernhard | 10 |
#8 | Picker Alexander | 10 |
#9 | Danes Christopher G | 8 |
#10 | Soldatos Theodoros | 8 |
Publication | Filing date | Title |
---|---|---|
EP3588506A1 | Systems and methods for genomic and genetic analysis | |
WO2017220782A1 | Screening method for endometrial cancer | |
AU2015204311A1 | Novel tissue protective erythropoietin receptor (NEPOR) and methods of use | |
AU2015203694A1 | Novel tissue protective erythropoietin receptor (NEPOR) and methods of use | |
EP2951745A1 | Systems and methods for clinical decision support | |
US2009306186A1 | Tissue protective erythropoietin receptor (NEPOR) and methods of use | |
EP2492355A1 | Tissue protective erythropoietin receptor (nepor) and methods of use |